SHL Group is looking forward to exhibiting at the Prefilled Syringe Seminar 2018 Tokyo held by the Parenteral Drug Association (PDA) Japan Chapter from May 22-23.
The annual seminar will bring together global pharma and medical device experts in an exploration of this year's theme: the best solution for the patient from the viewpoint of drugs, containers, and devices.
SHL Group will join the event with a showcase of its advanced drug delivery solutions, which include innovative offerings for high volume/high viscosity formulations designed to meet the needs of next-generation therapies.
For the first time in Japan, SHL will be demonstrating Maggie®, a high-volume cartridge-based auto injector built with the market-proven Needle Isolation Technology (NIT®). SHL will also present its high-volume Molly® 2.25, which offers a shorter development timeline for faster commercialization, and Rotaject®, a state-of-the-art constant force technology that safely delivers viscosities up to several hundred centipoise within seconds.
SHL is pleased to bring its latest portfolio to Japan, a leading market in Asia for self-administered injection devices, and to help biotech and pharma players from around the world to meet their clinical and commercialization needs.
To find out more about SHL's auto injection devices and digital solutions, stop by the Sola City Conference Center in Tokyo, Japan from May 22-23.
集團目前全球已有超過 3,700 名員工，主要分為以下事業群：
SHL Medical 主要為製藥和生技企業設計、研發、及製造高科技藥物傳輸系統，也提供終端組裝、醫材標籤及包裝相關服務
SHL Healthcare 從事居家及醫院護理器材之研發製造
SHL Technologies 提供醫療科技及工業設備之 OEM 製造與相關服務